Report on the first myelomatosis trial. I. Analysis of presenting features of prognostic importance.
D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D001536:Bence Jones Protein / Q000032:analysis; D002118:Calcium / Q000097:blood; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006454:Hemoglobins; D006801:Humans; D007075:Immunoglobulin M / Q000032:analysis; D008297:Male; D008558:Melphalan / Q000627:therapeutic use; D008875:Middle Aged; D009101:Multiple Myeloma / Q000097:blood / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000401:mortality; D011379:Prognosis; D011507:Proteinuria; D011859:Radiography; D012709:Serum Albumin / Q000032:analysis; D014508:Urea / Q000097:blood
D006454:Hemoglobins; D007075:Immunoglobulin M; D012709:Serum Albumin; D003520:Cyclophosphamide; D014508:Urea; D001536:Bence Jones Protein; D000469:Alkaline Phosphatase; D008558:Melphalan; D002118:Calcium